Top Markets
Coin of the day
Jiangsu Hengrui Medicine Co., Ltd. Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

600276
Rangering i aksjer #509
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Aksjekurs
$7.88
Sist synkronisert: 2026-08-12
Markedsverdi
$50.25B
Endring (1 dag)
-1.11%
Endring (1 år)
-9.73%
Land
CN
Handel Jiangsu Hengrui Medicine Co., Ltd. (600276)

Kategori

Historikk for aksjesplitt for Jiangsu Hengrui Medicine Co., Ltd. (600276)
Aksjen Jiangsu Hengrui Medicine Co., Ltd. (symbol: 600276) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 13, 2026.
Én 600276-aksje kjøpt før Aug 13, 2026 tilsvarer i dag 0 600276-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter